Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut
Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion.
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2024, the Compensation Committee of Crinetics' Board of Directors gra...
Nasdaq Rises to 5th in RiskTech100 Global Ranking Following Launch of Financial Technology Division
Announcement comes ahead of the first anniversary of Nasdaq's acquisition of Adenza Nasdaq also wins two awards for its financial crime management and regulatory reporting technology NEW YORK, Oct....
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and ...
Chinese Tech Stocks Slump as Nasdaq's Golden Dragon Index Dips
On Tuesday, major Chinese stocks experienced significant declines, leading to a 6.85% drop in the Nasdaq Golden Dragon China Index (HXC). Among those showing gains, Taiwan Semiconductor Manufacturi...
Nasdaq Surges Over 1%; DocuSign Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Tuesday.
Inno Holdings Inc. Announces 1-for-10 Reverse Stock Split
BROOKSHIRE, TX / ACCESSWIRE / October 8, 2024 / Inno Holdings Inc. ("Inno" or the "Company") (Nasdaq Capital Market:INHD), an innovative building-technology company with a mission to transform the ...
Nasdaq Launches PureStream in Europe – A new tool for trajectory trading
STOCKHOLM, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the planned launch of PureStream, a new volume-based trajectory trading solution giving clients access to EU share...
Nasdaq Reports September 2024 Volumes and 3Q24 Statistics
NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for September 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and...
Strong Performance by Nasdaq Golden Dragon China Index and Related ETFs
During China's "Golden Week" holiday, overseas Chinese stocks and funds experienced notable gains. The Nasdaq Golden Dragon China Index increased by 3.1%, reaching its highest level since February ...
You'll Never Guess the Best-Performing Stock in the Nasdaq-100 Last Quarter. Is It Still a Buy?
Hint: It wasn't Nvidia.
Is It Time to Buy September's Worst-Performing Nasdaq Stocks?
September is typically a bad month for stocks, but the Nasdaq still gained.
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical co...
Urgently Notified By Nasdaq Of Non-Compliance With Nasdaq Minimum Bid Price Requirement
Intends to Cure the Deficiency and Return to Compliance with Nasdaq Standard Intends to Cure the Deficiency and Return to Compliance with Nasdaq Standard
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant ...
Related Companies